<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Evaluation of the adult patient with hypokalemia
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Evaluation of the adult patient with hypokalemia
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Evaluation of the adult patient with hypokalemia
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David B Mount, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard H Sterns, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael Emmett, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John P Forman, MD, MSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypokalemia is a common clinical problem, the cause of which can usually be determined from the history (as with diuretic use, vomiting, or diarrhea). In some cases, however, the diagnosis is not readily apparent.
        </p>
        <p>
         The diagnostic approach to the patient with hypokalemia will be reviewed here. There are two major components to the diagnostic evaluation: assessment of urinary potassium excretion to distinguish renal potassium losses (eg, diuretic therapy, primary aldosteronism) from other causes of hypokalemia, and assessment of acid-base status, since some causes of hypokalemia are associated with metabolic alkalosis or metabolic acidosis.
        </p>
        <p>
         The causes, clinical manifestations, and treatment of hypokalemia are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2341.html" rel="external">
          "Causes of hypokalemia in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2297.html" rel="external">
          "Clinical manifestations and treatment of hypokalemia in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          REGULATION OF POTASSIUM EXCRETION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of the potassium filtered at the glomerulus is reabsorbed in the proximal tubule and loop of Henle, whereas most of the potassium that is excreted is derived from tubular secretion by the principal cells in the connecting tubule and cortical collecting tubule  (
         <a class="graphic graphic_figure graphicRef60693" href="/z/d/graphic/60693.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid1">
          1,2
         </a>
         ]. Aldosterone plays a central role in this process. An increase in plasma potassium stimulates the secretion of aldosterone, which then appropriately increases potassium secretion to return the plasma potassium to normal.
        </p>
        <p>
         The renal tubular response to potassium depletion is twofold:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Decreased potassium secretion by the principal cells
         </strong>
         – The effect of hypokalemia and potassium depletion on potassium secretion by the principal cells is mediated at least in part by the renin-angiotensin aldosterone system [
         <a href="#rid3">
          3-5
         </a>
         ]. Hypokalemia suppresses aldosterone secretion [
         <a href="#rid6">
          6
         </a>
         ], which results in reduced sodium reabsorption by principal cells. Decreased sodium reabsorption by these cells diminishes the electrogenic, lumen-negative stimulus for potassium secretion via apical potassium channels  (
         <a class="graphic graphic_figure graphicRef60693" href="/z/d/graphic/60693.html" rel="external">
          figure 1
         </a>
         ). In addition, potassium depletion increases renin release and systemic angiotensin II formation, which in turn downregulates apical secretory potassium channels, thereby directly inhibiting potassium secretion [
         <a href="#rid5">
          5
         </a>
         ]. Hypokalemia also activates the Na-Cl cotransporter (NCC) in distal convoluted tubule cells, which increases sodium reabsorption by the distal tubule and reduces delivery of sodium to principal cells, thereby blunting potassium secretion [
         <a href="#rid7">
          7-9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increased active potassium reabsorption
         </strong>
         <strong>
          by type A intercalated cells
         </strong>
         – Hypokalemia activates H-K-ATPase pumps in the apical membrane of type A intercalated cells, which are adjacent to the principal cells in the cortical collecting tubules  (
         <a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid2">
          2,10,11
         </a>
         ]. These pumps reabsorb potassium and secrete hydrogen.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6814660">
         <span class="h1">
          EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cause of hypokalemia is usually apparent from the history. As examples, patients may report vomiting, diarrhea, or the use of loop or thiazide diuretics. (See
         <a class="medical medical_review" href="/z/d/html/2341.html" rel="external">
          "Causes of hypokalemia in adults"
         </a>
         .)
        </p>
        <p>
         However, the cause is occasionally uncertain. In such cases, there are two major components to the diagnostic evaluation:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assessment of urinary potassium excretion to distinguish renal potassium losses (eg, diuretic therapy, primary aldosteronism) from other causes of hypokalemia (eg, gastrointestinal losses, transcellular potassium shifts). (See
         <a class="local">
          'Assessment of urinary potassium excretion'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assessment of acid-base status, since some causes of hypokalemia are associated with metabolic alkalosis or metabolic acidosis. (See
         <a class="local">
          'Assessment of acid-base status'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         Assessment of urinary potassium excretion is best accomplished by measuring potassium excretion in a 24-hour urine collection. Excretion of more than 30 mEq of potassium per day indicates inappropriate renal potassium loss. Measurement of the potassium and creatinine concentrations in a spot urine is an alternative if collection of a 24-hour urine is impractical. A spot urine potassium-to-creatinine ratio greater than 13 mEq/g creatinine (1.5 mEq/mmol) usually indicates inappropriate renal potassium loss. Causes of urinary potassium wasting are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2341.html" rel="external">
          "Causes of hypokalemia in adults", section on 'Increased urinary losses'
         </a>
         .)
        </p>
        <p>
         After determining whether renal potassium wasting is present, assessment of acid–base status can further narrow the differential diagnosis. (See
         <a class="local">
          'Assessment of acid-base status'
         </a>
         below.)
        </p>
        <p>
         It is critical to distinguish hypokalemia caused by redistribution, given the risk of rebound hyperkalemia that these patients may have after potassium repletion [
         <a href="#rid12">
          12
         </a>
         ]. As an example, rebound hyperkalemia (serum potassium greater than 5 mEq/L) developed in 19 of the 30 patients with periodic paralysis after administration of a mean of 63 mEq of
         <a class="drug drug_general" data-topicid="9795" href="/z/d/drug information/9795.html" rel="external">
          potassium chloride
         </a>
         [
         <a href="#rid13">
          13
         </a>
         ]. This effect is due both to reversal of the shift of extracellular potassium into the cells and to the administered potassium. (See
         <a class="medical medical_review" href="/z/d/html/5150.html" rel="external">
          "Hypokalemic periodic paralysis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5154.html" rel="external">
          "Thyrotoxic periodic paralysis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H60964991">
         <span class="h2">
          Assessment of urinary potassium excretion
         </span>
         <span class="headingEndMark">
          —
         </span>
         The best method for assessing renal potassium excretion is a 24-hour urine collection. However, the potassium concentration or, preferably, potassium-to-creatinine ratio on a spot urine are alternatives.
        </p>
        <p class="headingAnchor" id="H6814773">
         <span class="h3">
          24-hour urine potassium
         </span>
         <span class="headingEndMark">
          —
         </span>
         A 24-hour urine collection is the most accurate method to measure urinary potassium excretion. A normal individual can, in the presence of potassium depletion that is
         <strong>
          not
         </strong>
         due to urinary losses, lower urinary potassium excretion below 25 to 30 mEq per day on a 24-hour urine collection [
         <a href="#rid14">
          14
         </a>
         ]. Higher values suggest at least a contribution from urinary potassium wasting.
        </p>
        <p>
         In patients with severe hypokalemia, measurement of 24-hour potassium excretion is impractical because potassium repletion is urgently needed. In such patients, a spot urine potassium may be helpful as long as the urine sodium is greater than 30 to 40 mEq/L and the urine osmolality is greater than the plasma osmolality (suggesting that the patient is not polyuric). If the urine sodium is lower than 30 mEq/L and/or the urine osmolality is lower than the plasma osmolality, then the spot urine potassium concentration may be misleading. If so, comparable information can be obtained by calculating the urine potassium-to-creatinine ratio on a single urine specimen.
        </p>
        <p class="headingAnchor" id="H6814767">
         <span class="h3">
          Spot urine potassium concentration
         </span>
         <span class="headingEndMark">
          —
         </span>
         Random measurement of the urine potassium concentration can also be used. The minimum urine potassium concentration that can be achieved with hypokalemia is 5 to 15 mEq/L [
         <a href="#rid14">
          14
         </a>
         ]. Some have suggested that extrarenal losses are present if the urine potassium concentration is less than 15 mEq/L [
         <a href="#rid15">
          15
         </a>
         ], while substantially higher values suggest at least a component of potassium wasting.
        </p>
        <p>
         However, random measurements may be misleading since the urine potassium concentration is determined by both the amount of potassium in the urine and the urine volume. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A urine potassium concentration of less than 15 mEq/L can be seen in patients with renal potassium wasting in two settings: if the cause of potassium wasting has resolved (eg, the effect of the diuretic has worn off), or if the patient is polyuric, which may be due to impaired urinary concentrating ability and, possibly, increased thirst induced by the hypokalemia. (See
         <a class="medical medical_review" href="/z/d/html/2295.html" rel="external">
          "Hypokalemia-induced kidney dysfunction", section on 'Impaired urinary concentrating ability'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A urine potassium concentration of 40 mEq/L, which seems to favor urinary potassium wasting, can also represent appropriate potassium conservation of 20 mEq per day if the urine volume is only 500 mL due to a low rate of water intake.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients who are volume depleted, sodium and water delivery to the distal potassium secretory site may be substantially reduced. In this setting, the urine potassium concentration may be relatively high due to secondary hyperaldosteronism, but the urine volume and absolute amount of potassium excreted are relatively low [
         <a href="#rid3">
          3
         </a>
         ]. Urinary sodium excretion should be above 30 to 40 mEq per day to avoid this problem.
        </p>
        <p>
        </p>
        <p>
         Given these limitations, measurement of the urine potassium-to-creatinine ratio is preferred because it is not influenced by the urine volume. (See
         <a class="local">
          'Urine potassium-to-creatinine ratio'
         </a>
         below.)
        </p>
        <p>
         Another approach to distinguishing between extrarenal and renal causes of potassium loss is to assess the response to the administration of potassium. Patients with previous extrarenal losses (eg, diarrhea) that have ceased will respond to potassium replacement with an increase in serum potassium that will eventually return to normal. A similar response will occur with diuretic-induced hypokalemia if the diuretic has been discontinued. By contrast, potassium replacement in patients with ongoing renal potassium losses will modestly raise the serum potassium, which will be followed by an increase in urinary potassium losses to match intake, and a lesser degree of hypokalemia will persist. In addition, the serum potassium will fall back to the baseline level if potassium therapy is discontinued. (See
         <a class="medical medical_review" href="/z/d/html/2297.html" rel="external">
          "Clinical manifestations and treatment of hypokalemia in adults", section on 'Ongoing losses and the steady state'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H60965616">
         <span class="h3">
          Urine potassium-to-creatinine ratio
         </span>
         <span class="headingEndMark">
          —
         </span>
         Since creatinine is excreted at a near-constant rate, the urine potassium-to-creatinine ratio corrects for variations in urine volume. The urine potassium-to-creatinine ratio on a spot urine correlates with 24-hour urine potassium excretion [
         <a href="#rid16">
          16-18
         </a>
         ].
        </p>
        <p>
         The urine potassium-to-creatinine ratio is usually less than 13 mEq/g creatinine (1.5 mEq/mmol creatinine) when hypokalemia is caused by transcellular potassium shifts, gastrointestinal losses, or prior use of diuretics (ie, after the effect of the diuretic has dissipated) [
         <a href="#rid13">
          13,19
         </a>
         ]. Higher values are seen with active renal potassium wasting (including diuretics, when the effect on the kidney is still present).
        </p>
        <p>
         The utility of the urine potassium-to-creatinine ratio was evaluated in a study of 43 patients with severe hypokalemia (range, 1.5 to 2.6 mEq/L) associated with paralysis [
         <a href="#rid13">
          13
         </a>
         ]. The urine potassium-to-creatinine ratio reliably distinguished between the 30 patients with hypokalemic periodic paralysis (whose hypokalemia was caused by an internal shift of potassium from the extracellular fluid into the cells) and the 13 patients with hypokalemia due mostly to renal potassium wasting (10 had renal tubular acidosis or Gitelman syndrome). The urine potassium-to-creatinine ratio was significantly lower in the patients with periodic paralysis (11 versus 36 mEq/g creatinine [1.3 versus 4.1 mEq/mmol creatinine]). The cutoff value was approximately 22 mEq/g creatinine (2.5 mEq/mmol). In addition, patients with periodic paralysis had normal acid-base balance, while patients without periodic paralysis often had metabolic alkalosis or metabolic acidosis. (See
         <a class="local">
          'Assessment of acid-base status'
         </a>
         below.)
        </p>
        <p>
         One theoretical limitation of the urinary potassium-to-creatinine ratio is patients with low creatinine excretion, for example, due to very low muscle mass; the urinary transtubular potassium gradient (TTKG) may be a preferable test in such patients. (See
         <a class="local">
          'Transtubular potassium gradient'
         </a>
         below.)
        </p>
        <p>
         The urine potassium-to-creatinine ratio may be elevated in many patients with gastrointestinal causes of hypokalemia (eg, bulimia or laxative abuse) [
         <a href="#rid19">
          19
         </a>
         ]. These causes of hypokalemia are associated with metabolic alkalosis rather than metabolic acidosis, and the associated metabolic alkalosis and rise in plasma bicarbonate concentration increase the filtered bicarbonate load above its reabsorptive threshold. As a result, more sodium and bicarbonate are delivered to the distal potassium secretory site. In combination with a hypovolemia-induced increase in aldosterone release, the net effect is increased potassium secretion and potentially large urinary potassium losses. In such cases, the ratio of urinary sodium-to-chloride concentrations can be helpful. Patients with renal tubular disorders such as Gitelman syndrome and Bartter syndrome tend to have coupled urinary sodium and chloride losses (ie, ratio of 1:1). By contrast, patients with bulimia tend to have high, "uncoupled" urinary sodium-to-chloride ratios (approximately 5:1), whereas patients with laxative abuse exhibit low urinary sodium-to-chloride ratios (approximately 0.4) [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3307184202">
         <span class="h3">
          Transtubular potassium gradient
         </span>
         <span class="headingEndMark">
          —
         </span>
         Another widely used index of urinary potassium excretion is the "transtubular potassium gradient" (TTKG) [
         <a href="#rid20">
          20
         </a>
         ], which is defined as follows:
        </p>
        <div class="formulaContainer">
         <div class="formula">
          <p>
           [potassium]urine  ×  serum osmolality
           <br/>
           TTKG  =   -------------------------------------------
           <br/>
           [potassium]blood  ×  urine osmolality
          </p>
         </div>
        </div>
        <p>
         In the absence of renal potassium wasting, the expected value of the TTKG is less than 3 to 4 in the presence of hypokalemia. Values higher than this suggest renal potassium wasting.
        </p>
        <p>
         Some groups have suggested that the TTKG is unreliable since it fails to incorporate postulated effects of distal tubular urea reabsorption in potassium excretion; however, neither urea transporter knockout mice nor rats treated with a urea transporter inhibitor demonstrate abnormalities in potassium homeostasis [
         <a href="#rid21">
          21
         </a>
         ]. Regardless of the theoretical limitations, the TTKG continues to be used as an index of urinary potassium wasting in clinical studies and in practice [
         <a href="#rid13">
          13,19
         </a>
         ]. The author typically utilizes both the TTKG and the urine potassium-to-creatinine ratio in the bedside evaluation of patients with hypokalemia.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          ASSESSMENT OF ACID-BASE STATUS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Once urinary potassium excretion is measured, the following diagnostic possibilities should be considered in the patient with hypokalemia of uncertain origin [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Assessment of acid-base status should include measurement of the serum bicarbonate, albumin, chloride, and in some cases, urine pH, urine electrolytes, and venous or arterial blood gas analysis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic acidosis with a low rate of urinary potassium excretion is, in an asymptomatic patient, suggestive of lower gastrointestinal losses due to laxative abuse or a villous adenoma [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2320.html" rel="external">
          "Acid-base and electrolyte abnormalities with diarrhea"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2628.html" rel="external">
          "Factitious diarrhea: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic acidosis with urinary potassium wasting is most often due to diabetic ketoacidosis or to type 1 (distal) or type 2 (proximal) renal tubular acidosis (RTA). (See
         <a class="medical medical_review" href="/z/d/html/2327.html" rel="external">
          "Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2328.html" rel="external">
          "Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic alkalosis with a low rate of urinary potassium excretion may be due to surreptitious vomiting (often in bulimic patients in an attempt to lose weight) or diuretic use if the urine collection is obtained after the diuretic effect has worn off. In addition, some patients with laxative abuse present with metabolic alkalosis, rather than the expected metabolic acidosis [
         <a href="#rid23">
          23,24
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2330.html" rel="external">
          "Pathogenesis of metabolic alkalosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic alkalosis with urinary potassium wasting:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In the setting of normal blood pressure, this is most often due to diuretic use, vomiting, or Gitelman or Bartter syndrome [
         <a href="#rid25">
          25,26
         </a>
         ]. In this setting, measurement of the urine chloride concentration is often helpful [
         <a href="#rid25">
          25,26
         </a>
         ], being normal (equal to intake) in Gitelman or Bartter syndrome, high or low with diuretics depending upon whether the diuretic is still acting, and low in vomiting at a time when urinary sodium and potassium excretion may be relatively high due to the need to maintain electroneutrality as some of the excess bicarbonate is being excreted. The last possibility can be determined at the bedside from the urine pH, which should be above 7 if significant bicarbonaturia is present. (See
         <a class="medical medical_review" href="/z/d/html/2344.html" rel="external">
          "Inherited hypokalemic salt-losing tubulopathies: Pathophysiology and overview of clinical manifestations"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In the setting of hypertension, this is suggestive of surreptitious diuretic therapy in a patient with underlying hypertension, renovascular disease, or one of the causes of primary mineralocorticoid excess. (See
         <a class="medical medical_review" href="/z/d/html/138.html" rel="external">
          "Diagnosis of primary aldosteronism"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1773822303">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/109733.html" rel="external">
          "Society guideline links: Fluid and electrolyte disorders in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H368476019">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/87109.html" rel="external">
          "Patient education: Hypokalemia (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H33681604">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In most patients with hypokalemia, the cause is apparent from the history (eg, vomiting, diarrhea, diuretic therapy). However, the cause is not apparent from the history in some patients. In such cases, there are two major components to the diagnostic evaluation (see
         <a class="local">
          'Evaluation'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Assessment of urinary potassium excretion to distinguish renal potassium losses (eg, diuretic therapy, primary aldosteronism) from other causes of hypokalemia (eg, gastrointestinal losses, transcellular potassium shifts). (See
         <a class="local">
          'Assessment of urinary potassium excretion'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Assessment of acid-base status, since some causes of hypokalemia are associated with metabolic alkalosis or metabolic acidosis. (See
         <a class="local">
          'Assessment of acid-base status'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The best method for assessing renal potassium excretion is a 24-hour urine collection. However, the potassium concentration or, preferably, potassium-to-creatinine ratio on a spot urine are alternatives (see
         <a class="local">
          'Assessment of urinary potassium excretion'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A normal individual can, in the presence of potassium depletion that is
         <strong>
          not
         </strong>
         due to urinary losses, lower urinary potassium excretion below 25 to 30 mEq per day on a 24-hour urine collection. Higher values suggest at least a contribution from urinary potassium wasting. (See
         <a class="local">
          '24-hour urine potassium'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Since creatinine is excreted at a near-constant rate, the urine potassium-to-creatinine ratio corrects for variations in urine volume. The urine potassium-to-creatinine ratio is usually less than 13 mEq/g creatinine (1.5 mEq/mmol creatinine) when hypokalemia is caused by transcellular potassium shifts, gastrointestinal losses, previous use of diuretics, or poor dietary intake. Higher values are seen with renal potassium wasting. (See
         <a class="local">
          'Urine potassium-to-creatinine ratio'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acid-base status should be evaluated (see
         <a class="local">
          'Assessment of acid-base status'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Metabolic acidosis with a low rate of potassium excretion suggests lower gastrointestinal losses.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Metabolic acidosis with renal potassium wasting may be seen with diabetic ketoacidosis and type 1 (distal) or type 2 (proximal) renal tubular acidosis (RTA).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Metabolic alkalosis with a low rate of renal potassium excretion suggests surreptitious vomiting, diuretic use (when the urine collection is obtained after the diuretic effect has worn off), or, rarely, laxative abuse.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Metabolic alkalosis with renal potassium wasting and a normal blood pressure is most often due to diuretic use, vomiting, or Gitelman or Bartter syndrome.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Metabolic alkalosis with potassium wasting and hypertension occurs with primary mineralocorticoid excess or a disorder that mimics a mineralocorticoid excess state, renovascular disease, or the surreptitious ingestion of diuretics by a patient with underlying hypertension.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Measurement of urine sodium and chloride can also provide important diagnostic clues (see
         <a class="local">
          'Urine potassium-to-creatinine ratio'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients with hypokalemia due to bulimia can have urine sodium concentrations five times the urine chloride concentration, whereas patients with hypokalemia due to laxative abuse may have urine sodium concentrations that are substantially lower than the urine chloride concentration.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients with renal loss of potassium (Gitelman and Bartter syndrome, distal RTA, active diuretic therapy) tend to have urine sodium and chloride concentrations that are equivalent.
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.863.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanton BA. Renal potassium transport: morphological and functional adaptations. Am J Physiol 1989; 257:R989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young DB. Quantitative analysis of aldosterone's role in potassium regulation. Am J Physiol 1988; 255:F811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Linas SL, Peterson LN, Anderson RJ, et al. Mechanism of renal potassium conservation in the rat. Kidney Int 1979; 15:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang WH, Giebisch G. Regulation of potassium (K) handling in the renal collecting duct. Pflugers Arch 2009; 458:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Himathongkam T, Dluhy RG, Williams GH. Potassim-aldosterone-renin interrelationships. J Clin Endocrinol Metab 1975; 41:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Terker AS, Zhang C, McCormick JA, et al. Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride. Cell Metab 2015; 21:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wade JB, Fang L, Coleman RA, et al. Differential regulation of ROMK (Kir1.1) in distal nephron segments by dietary potassium. Am J Physiol Renal Physiol 2011; 300:F1385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vallon V, Schroth J, Lang F, et al. Expression and phosphorylation of the Na+-Cl- cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1. Am J Physiol Renal Physiol 2009; 297:F704.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wingo CS, Smolka AJ. Function and structure of H-K-ATPase in the kidney. Am J Physiol 1995; 269:F1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okusa MD, Unwin RJ, Velázquez H, et al. Active potassium absorption by the renal distal tubule. Am J Physiol 1992; 262:F488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ko GT, Chow CC, Yeung VT, et al. Thyrotoxic periodic paralysis in a Chinese population. QJM 1996; 89:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin SH, Lin YF, Chen DT, et al. Laboratory tests to determine the cause of hypokalemia and paralysis. Arch Intern Med 2004; 164:1561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           SQUIRES RD, HUTH EJ. Experimental potassium depletion in normal human subjects. I. Relation of ionic intakes to the renal conservation of potassium. J Clin Invest 1959; 38:1134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groeneveld JH, Sijpkens YW, Lin SH, et al. An approach to the patient with severe hypokalaemia: the potassium quiz. QJM 2005; 98:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tanaka T, Okamura T, Miura K, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens 2002; 16:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hooft van Huysduynen EJ, Hulshof PJ, van Lee L, et al. Evaluation of using spot urine to replace 24 h urine sodium and potassium excretions. Public Health Nutr 2014; 17:2505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol 1993; 20:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu KL, Cheng CJ, Sung CC, et al. Identification of the Causes for Chronic Hypokalemia: Importance of Urinary Sodium and Chloride Excretion. Am J Med 2017; 130:846.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           West ML, Marsden PA, Richardson RM, et al. New clinical approach to evaluate disorders of potassium excretion. Miner Electrolyte Metab 1986; 12:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cil O, Esteva-Font C, Tas ST, et al. Salt-sparing diuretic action of a water-soluble urea analog inhibitor of urea transporters UT-A and UT-B in rats. Kidney Int 2015; 88:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           SCHWARTZ WB, RELMAN AS. Metabolic and renal studies in chronic potassium depletion resulting from overuse of laxatives. J Clin Invest 1953; 32:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ewe K, Karbach U. Factitious diarrhoea. Clin Gastroenterol 1986; 15:723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oster JR, Materson BJ, Rogers AI. Laxative abuse syndrome. Am J Gastroenterol 1980; 74:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woywodt A, Herrmann A, Eisenberger U, et al. The tell-tale urinary chloride. Nephrol Dial Transplant 2001; 16:1066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reimann D, Gross P. Chronic, diagnosis-resistant hypokalaemia. Nephrol Dial Transplant 1999; 14:2957.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2305 Version 30.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.863.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2686470" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Renal potassium transport: morphological and functional adaptations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3056039" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Quantitative analysis of aldosterone's role in potassium regulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/222934" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Mechanism of renal potassium conservation in the rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18839206" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Regulation of potassium (K) handling in the renal collecting duct.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1167307" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Potassim-aldosterone-renin interrelationships.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25565204" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21454252" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Differential regulation of ROMK (Kir1.1) in distal nephron segments by dietary potassium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19570885" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Expression and phosphorylation of the Na+-Cl- cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7631822" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Function and structure of H-K-ATPase in the kidney.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1532693" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Active potassium absorption by the renal distal tubule.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8758050" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Thyrotoxic periodic paralysis in a Chinese population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15277290" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Laboratory tests to determine the cause of hypokalemia and paralysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13664789" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Experimental potassium depletion in normal human subjects. I. Relation of ionic intakes to the renal conservation of potassium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15760922" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : An approach to the patient with severe hypokalaemia: the potassium quiz.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11850766" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24909492" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Evaluation of using spot urine to replace 24 h urine sodium and potassium excretions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8432042" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28213045" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Identification of the Causes for Chronic Hypokalemia: Importance of Urinary Sodium and Chloride Excretion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3762510" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : New clinical approach to evaluate disorders of potassium excretion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25993324" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Salt-sparing diuretic action of a water-soluble urea analog inhibitor of urea transporters UT-A and UT-B in rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13044835" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Metabolic and renal studies in chronic potassium depletion resulting from overuse of laxatives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3527500" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Factitious diarrhoea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7234824" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Laxative abuse syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11328919" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : The tell-tale urinary chloride.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10570107" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Chronic, diagnosis-resistant hypokalaemia.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
